Poison Ivy

Manufacturer
Newton Laboratories, Inc.
Effective date
2011-06-01
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:05:08

Label at a glance#

ProductPoison Ivy
Active ingredientXerophyllum Asphodeloides, Aconitum Napellus, Anacardium Occidentale Fruit, Apis Mellifera, Bryonia Alba Root, Lytta Vesicatoria, Croton Tiglium Seed, Graphite, Grindelia Hirsutula Flowering Top, Daphne Mezereum Bark, Strychnos Nux-vomica Seed, Ranunculus Bulbosus, Toxicodendron Pubescens Leaf, Smilax Regelii Root, Echinacea, Unspecified, Rumex Crispus Root, Taraxacum Officinale, Urtica Urens, Sulfur
Label structure10 sections

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

INDICATIONS & USAGE SECTION

Poison Ivy  Formulated for symptoms associated with poison ivy, oak and sumac such as itching, burning, pain, swelling and blistering.

DOSAGE & ADMINISTRATION SECTION

DOSAGE & ADMINISTRATION SECTION

Directions:  Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) as needed or as directed by a healthcare professional.  Under age 2, crush or dissolve pellets in purified water.

ACTIVE INGREDIENT SECTION

OTC - ACTIVE INGREDIENT SECTION

Xerophyllum asphodeloides 30x, Aconitum nap. 15x, Anacardium occidentale 15x, Apis mel. 15x, Bryonia 15x, Cantharis 15x, Croton 15x, Graphites 15x, Grindelia 15x, Mezereum 15x, Nux vom. 15x, Ranunc. bulb. 15x, Rhus toxicodendron 15x, Sarsaparilla 15x, Sulphur 15x, Echinacea 3x, Rumex crisp. 3x, Taraxacum 3x, Urtica ur. 3x.

PURPOSE SECTION

ABUSE SECTION

Formulated for symptoms associated with poison ivy, oak and sumac such as itching, burning, pain, swelling and blistering.

INACTIVE INGREDIENT SECTION

Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS? SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net  Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions?  1.800.448.7256

WARNINGS SECTION

Warning:  Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.

PREGNANCY OR BREAST FEEDING SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. 

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

package label
package label
package label
package label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
55714-4477-12020-01-31C16284748780-19d75b9d0-b5c6-f424-e053-dadaa90a57cePoison Ivy
55714-4477-22020-01-31C16284748780-19d75b9d0-b5c6-f424-e053-dadaa90a57cePoison Ivy

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55714-4477-1Poison Ivy28.35 g in 1 BOTTLE, GLASSPELLET28.351
55714-4477-2Poison Ivy56.7 g in 1 BOTTLE, GLASSPELLET56.71

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55714-4477POISON IVY (XEROPHYLLUM ASPHODELOIDES, ACONITUM NAP., ANACARDIUM OCCIDENTALE, APIS MEL., BRYONIA, CANTHARIS, CROTON, GRAPHITES, GRINDELIA, MEZEREUM, NUX VOM., RANUNC. BULB., RHUS TOXICODENDRON, SARSAPARILLA, SULPHUR, ECHINACEA, RUMEX CRISP., TARAXACUM, URTICA UR.) PELLET [NEWTON LABORATORIES, INC.]1Legacy NDC, 2 package rows20131105_04be40dd-0ec7-00ac-4483-5ad8015e6b80.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Aconitum NapellusACTIVE INGREDIENTU0NQ8555JD1
Anacardium Occidentale FruitACTIVE INGREDIENT4A10JR4E7E1
Apis MelliferaACTIVE INGREDIENT7S82P3R43Z1
Bryonia Alba RootACTIVE INGREDIENTT7J046YI2B1
Croton Tiglium SeedACTIVE INGREDIENT0HK2GZK66E1
Daphne Mezereum BarkACTIVE INGREDIENTX2N6E405GV1
Echinacea, UnspecifiedACTIVE INGREDIENT4N9P6CC1DX1
GraphiteACTIVE INGREDIENT4QQN74LH4O1
Grindelia Hirsutula Flowering TopACTIVE INGREDIENTIDB0NAZ6AI1
Lytta VesicatoriaACTIVE INGREDIENT3Q034RO3BT1
Ranunculus BulbosusACTIVE INGREDIENTAEQ8NXJ0MB1
Rumex Crispus RootACTIVE INGREDIENT9N1RM2S62C1
Smilax Regelii RootACTIVE INGREDIENT2H1576D5WG1
Strychnos Nux-vomica SeedACTIVE INGREDIENT269XH139191
SulfurACTIVE INGREDIENT70FD1KFU701
Taraxacum OfficinaleACTIVE INGREDIENT39981FM3751
Toxicodendron Pubescens LeafACTIVE INGREDIENT6IO182RP7A1
Urtica UrensACTIVE INGREDIENTIHN2NQ5OF91
Xerophyllum AsphodeloidesACTIVE INGREDIENT9I4XB1GP2B1
Aconitum NapellusACTIVE MOIETYU0NQ8555JD1
Anacardium Occidentale FruitACTIVE MOIETY4A10JR4E7E1
Apis MelliferaACTIVE MOIETY7S82P3R43Z1
Bryonia Alba RootACTIVE MOIETYT7J046YI2B1
Croton Tiglium SeedACTIVE MOIETY0HK2GZK66E1
Daphne Mezereum BarkACTIVE MOIETYX2N6E405GV1
Echinacea, UnspecifiedACTIVE MOIETY4N9P6CC1DX1
GraphiteACTIVE MOIETY4QQN74LH4O1
Grindelia Hirsutula Flowering TopACTIVE MOIETYIDB0NAZ6AI1
Lytta VesicatoriaACTIVE MOIETY3Q034RO3BT1
Ranunculus BulbosusACTIVE MOIETYAEQ8NXJ0MB1
Rumex Crispus RootACTIVE MOIETY9N1RM2S62C1
Smilax Regelii RootACTIVE MOIETY2H1576D5WG1
Strychnos Nux-vomica SeedACTIVE MOIETY269XH139191
SulfurACTIVE MOIETY70FD1KFU701
Taraxacum OfficinaleACTIVE MOIETY39981FM3751
Toxicodendron Pubescens LeafACTIVE MOIETY6IO182RP7A1
Urtica UrensACTIVE MOIETYIHN2NQ5OF91
Xerophyllum AsphodeloidesACTIVE MOIETY9I4XB1GP2B1
SucroseINACTIVE INGREDIENTC151H8M5541

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55714-447755714-4477-1, 55714-4477-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SucroseSUCROSEC151H8M554ELIXIR / ORAL18000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET / ORAL4249 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554WAFER / ORAL155.2 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTABLE, LIPOSOMAL / INTRAVENOUS7560 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SOLUTION / ORAL42596 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CONCENTRATE / ORAL4800 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, EXTENDED RELEASE / ORAL284.54 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LIQUID / ORAL37500 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SOLUTION / RECTAL35.42 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, FILM COATED, EXTENDED RELEASE / ORAL119.12 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER, FOR SOLUTION / ORAL38666 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS2000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, CHEWABLE / ORAL7258 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION, EXTENDED RELEASE / ORAL5400 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SYRUP / ORAL46400 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, DELAYED RELEASE / ORAL295.33 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TROCHE / BUCCALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS9.4 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET / SUBLINGUAL109 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS900 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SUSPENSION / ORAL31885 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, COATED PELLETS / ORAL59.8 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS1 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET / BUCCAL109 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TROCHE / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, EMULSION / INTRAVENOUS970 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUPPOSITORY / RECTALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION / SUBCUTANEOUS47.75 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION / INTRAVENOUS1950 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SOLUTION / ORAL70000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, FILM COATED / ORAL145 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LOZENGE / BUCCALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554DROPS / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER, FOR SUSPENSION / ORAL40017 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554PASTILLE / ORAL426 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, COATED, EXTENDED RELEASE / ORAL86 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION/ DROPS / ORAL3750 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS308 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE / ORAL3568 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LOZENGE / TRANSMUCOSAL1255 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, EXTENDED RELEASE / ORAL619 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, DELAYED RELEASE / ORAL955 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION / ORAL48209 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, COATED / ORAL516.42 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL18790 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER / ORAL27768 mgExact identifier — unii candidate
48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
dc85be41-7f90-4d68-f98b-b401d3b0c10904be40dd-0ec7-00ac-4483-5ad8015e6b802011-06-01WarningsExact identifier
spl id: dc85be41-7f90-4d68-f98b-b401d3b0c109
spl set id: 04be40dd-0ec7-00ac-4483-5ad8015e6b80

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.